January 25, 2018 / 8:50 PM / in 17 minutes Illumina wins $26.7 million in patent fight with Roche unit Ariosa Reuters Staff 1 Min Read 
Jan 25 (Reuters) - Gene testing company Illumina on Thursday won a $26.7 million jury verdict in a U.S. lawsuit accusing rival Ariosa Diagnostics, a subsidiary of Roche Holdings AG, of using patented prenatal testing technology without authorization. 
A federal jury in San Francisco said Ariosaâ€™s Harmony non-invasive prenatal test kits infringed on two Illumina patents. 
Illumina had sought more than $100 million in damages. Reporting by Jan Wolfe; Editing by Cynthia Osterman